Lytix Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 23.8%.

Top 24 shareholders own 62.52% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.5%	Citigroup Inc.,Banking and Securities Investments	4,711,409	NOK 32.0m	0%	no data
8.93%	Jakob Hatteland Holding AS	4,428,816	NOK 30.1m	0%	no data
5.62%	Taj Holding As	2,788,900	NOK 19.0m	0%	no data
4.92%	Lyr Invest As	2,438,863	NOK 16.6m	0%	no data
3.75%	Waatvika As	1,860,764	NOK 12.7m	0%	no data
3.65%	3T Produkter Holding AS	1,808,764	NOK 12.3m	0%	no data
3.45%	BrøDrene Karlsen Holding A/S	1,709,274	NOK 11.6m	0%	no data
3.05%	Per Strand Eiendom As	1,510,769	NOK 10.3m	0%	no data
2.66%	Hifo Invest AS	1,318,913	NOK 9.0m	0%	no data
2.66%	Saturn Invest AS	1,318,913	NOK 9.0m	0%	no data
2.06%	Care Holding As	1,024,287	NOK 7.0m	0%	no data
1.8%	Kvasshøgdi AS	890,986	NOK 6.1m	0%	no data
1.53%	Belvedere AS	760,430	NOK 5.2m	0%	no data
1.49%	Jahatt AS	738,167	NOK 5.0m	0%	no data
1.4%	Picasso AS	695,753	NOK 4.7m	0%	no data
1.35%	Skandinaviska Enskilda Banken AB, Asset Management Arm	669,115	NOK 4.5m	0%	0.06%
1.24%	Lysnes Invest As	615,654	NOK 4.2m	0%	no data
1.12%	Norinnova Invest AS	557,510	NOK 3.8m	0%	no data
1.04%	North Murray AS	516,814	NOK 3.5m	0%	no data
0.99%	Dragesund Invest AS	490,839	NOK 3.3m	0%	no data
0.28%	Oystein Rekdal	139,963	NOK 951.7k	0%	no data
0.022%	Gjest Breistein	11,112	NOK 75.6k	0%	no data
0.01%	Gry Stensrud	5,000	NOK 34.0k	0%	no data
0.0086%	Baldur Sveinbjørnsson	4,280	NOK 29.1k	0%	no data